Apex Biotechnology Corp. (TPE:1733)
Taiwan
· Delayed Price · Currency is TWD 28.50
-0.90 (-3.06%)
At close: Mar 9, 2026
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 2.85 billion as of March 9, 2026. Its market cap has decreased by -10.80% in one year.
Market Cap
2.85B
Enterprise Value
2.40B
Revenue
1.96B
Ranking
n/a
PE Ratio
19.00
Stock Price
28.50
Market Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 2.85B, an increase of 99.90%. That is a compound annual growth rate of 2.87%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3D Global Biotech | 3.05B |
| Syngen Biotech | 3.10B |
| GlycoNex Incorporation | 2.71B |
| SYN-TECH Chem. & Pharm. | 3.19B |
| Intech Biopharm | 3.38B |
| Sunny Pharmtech | 2.54B |
| Sinew Pharma | 2.54B |
| Synbio Tech | 2.53B |